US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wellgistics Health Inc.

0.6992

-0.0872-11.09%

Post-market: 0.6950-0.0042-0.60%19:59 EDT

Volume:4.44M

Turnover:3.14M

Market Cap:63.91M

PE:-0.81

High:0.7699

Open:0.7000

Low:0.6700

Close:0.7864

52wk High:7.04

52wk Low:0.3357

Shares:91.41M

Float Shares:26.12M

Volume Ratio:0.03

T/O Rate:17.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8668

EPS(LYR):-0.1451

ROE:-2124.65%

ROA:-90.63%

PB:70.60

PE(LYR):-4.82

Loading ...

Overview Company News Filings

Wellgistics Health Inc - Eric Sherb Appointed Interim CFO - SEC Filing

THOMSON REUTERS

Wellgistics Health Inc announces CEO COO and CFO resignations appoints Eric Sherb as interim CFO

Wellgistics Health Inc Announces New Leadership Changes

Wellgistics Health Inc. Announces Board Shakeup: New Directors Appointed Following Removals and Resignation

Wellgistics Health Inc Announces Successful Stock Offering

Wellgistics Health Inc. Announces $5 Million Public Offering of Common Stock and Warrants

Wellgistics Health Inc. and TheracosBio Announce Partnership to Expand Nationwide Access to Brenzavvy Through 6,500 Pharmacies

Wellgistics Health prices 7.14M share offering at 70c per share

Wellgistics Health Inc. Announces $5 Million Public Offering of Shares and Warrants at $0.70 Per Unit

Wellgistics Health Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

BRIEF-Wellgistics Health Enters $1.3 Million Loan Agreement

Wellgistics Health Inc - Agile Loan Matures on April 8, 2026 - SEC Filing

THOMSON REUTERS

Wellgistics Health H1 2025 Revenue On Pro Forma Basis $18.65M Up From $18.25M YoY

Wellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024

Wellgistics Health Inc - on August 13, 2025, Terminates $50 Mln Eloc Purchase Agreement - SEC Filing

THOMSON REUTERS

Wellgistics Health Inc. Delays Quarterly Report Due to Change in Accounting Firm

Wellgistics Health Inc. Replaces Suri & Co. with UHY LLP as New Accounting Firm Following Going Concern Note

Wellgistics Health Inc. Files Initial Beneficial Ownership Statement, Naming Michael Peterson as Director

Wellgistics Health Inc. Reports Major Expansion in Q2 2025 with 116 New Manufacturer Partnerships and Over 12,400 New Products

Wellgistics Health Inc. Joins Forces with OptiSource to Bolster Independent Pharmacies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/WGRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WGRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WGRX\",,,,,undefined,":{"symbol":"WGRX","market":"US","secType":"STK","nameCN":"Wellgistics Health Inc.","latestPrice":0.6992,"timestamp":1761940800000,"preClose":0.7864,"halted":0,"volume":4440515,"hourTrading":{"tag":"盘后","latestPrice":0.695,"preClose":0.6992,"latestTime":"19:59 EDT","volume":97135,"amount":67287.59575,"timestamp":1761955164189},"delay":0,"floatShares":26116000,"shares":91407000,"eps":-0.866822,"marketStatus":"Market Closed","change":-0.0872,"latestTime":"10-31 16:00:00 EDT","open":0.7,"high":0.7699,"low":0.67,"amount":3143436.26120045,"amplitude":0.127035,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.866822,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":7,"adr":0,"listingDate":1740114000000,"exchange":"NASDAQ","adjPreClose":0.7864,"preHourTrading":{"tag":"盘前","latestPrice":0.7,"preClose":0.7864,"latestTime":"09:29 EDT","volume":371036,"amount":264660.813631,"timestamp":1761917394272},"postHourTrading":{"tag":"盘后","latestPrice":0.695,"preClose":0.6992,"latestTime":"19:59 EDT","volume":97135,"amount":67287.59575,"timestamp":1761955164189},"volumeRatio":0.028306},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WGRX\",,,,,undefined,":{"symbol":"WGRX","floatShares":26116000,"roa":"-90.63%","roe":"-2124.65%","lyrEps":-0.145098,"volumeRatio":0.028306,"shares":91407000,"dividePrice":0,"high":0.7699,"amplitude":0.127035,"preClose":0.7864,"low":0.67,"week52Low":0.3357,"pbRate":"70.60","psRate":"1.74","week52High":7.04,"institutionHeld":0,"latestPrice":0.6992,"eps":-0.866822,"divideRate":0,"volume":4440515,"delay":0,"ttmEps":-0.866822,"open":0.7,"prevYearClose":4.5,"prevWeekClose":1.15,"prevMonthClose":0.8871,"prevQuarterClose":0.8871,"fiveDayClose":1.15,"twentyDayClose":0.6784,"sixtyDayClose":0.7585},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WGRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-19","symbol":"WGRX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755576000000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2025-05-12","symbol":"WGRX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.62}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WGRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WGRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/WGRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"WGRX","date":"2025-10-30","current":-0.806625,"percent":0.891429,"low":-72.147882,"twenty":-32.577822,"median":-2.286683,"eighty":-1.381414,"high":-0.723957,"avg":-13.627444,"sd":18.540334,"marketCap":57047084},"quantilePoints":[{"date":"2025-02-21","current":-72.147882,"twenty":-72.147882,"median":-72.147882,"eighty":-72.147882,"marketCap":259777540},{"date":"2025-02-28","current":-42.846677,"twenty":-68.711291,"median":-43.712266,"eighty":-40.423027,"marketCap":154274859},{"date":"2025-03-07","current":-41.836823,"twenty":-52.714396,"median":-41.836823,"eighty":-39.470878,"marketCap":150638751},{"date":"2025-03-14","current":-38.51873,"twenty":-43.539148,"median":-41.404028,"eighty":-38.951524,"marketCap":138691539},{"date":"2025-03-21","current":-68.309433,"twenty":-56.926931,"median":-41.836823,"eighty":-39.038083,"marketCap":245956719},{"date":"2025-03-28","current":-29.320039,"twenty":-57.648256,"median":-41.836823,"eighty":-38.951524,"marketCap":201024816},{"date":"2025-04-04","current":-34.168831,"twenty":-57.330873,"median":-41.548293,"eighty":-35.027382,"marketCap":234269230},{"date":"2025-04-11","current":-29.623089,"twenty":-56.580696,"median":-39.817114,"eighty":-32.608127,"marketCap":203102592},{"date":"2025-04-17","current":-27.804792,"twenty":-54.964929,"median":-38.951524,"eighty":-29.850376,"marketCap":190635936},{"date":"2025-04-25","current":-32.350534,"twenty":-50.348452,"median":-38.446597,"eighty":-29.623089,"marketCap":221802575},{"date":"2025-05-02","current":-32.786877,"twenty":-43.712266,"median":-34.623406,"eighty":-29.850376,"marketCap":224794239},{"date":"2025-05-09","current":-22.874565,"twenty":-42.846677,"median":-34.582242,"eighty":-29.850376,"marketCap":156833190},{"date":"2025-05-16","current":-3.107007,"twenty":-41.836823,"median":-34.006854,"eighty":-28.941227,"marketCap":121807110},{"date":"2025-05-23","current":-3.897505,"twenty":-41.836823,"median":-32.863125,"eighty":-24.925822,"marketCap":152797794},{"date":"2025-05-30","current":-3.661768,"twenty":-41.836823,"median":-32.653584,"eighty":-18.358625,"marketCap":143555992},{"date":"2025-06-06","current":-2.734539,"twenty":-41.721411,"median":-31.592911,"eighty":-3.859787,"marketCap":107204904},{"date":"2025-06-13","current":-2.21592,"twenty":-41.461734,"median":-30.346923,"eighty":-3.639588,"marketCap":86872939},{"date":"2025-06-20","current":-1.917321,"twenty":-40.624998,"median":-29.926138,"eighty":-3.31177,"marketCap":75166657},{"date":"2025-06-27","current":-1.744448,"twenty":-39.932526,"median":-29.850376,"eighty":-2.948274,"marketCap":68389335},{"date":"2025-07-03","current":-1.430133,"twenty":-39.643996,"median":-29.320039,"eighty":-2.747112,"marketCap":56066932},{"date":"2025-07-11","current":-1.571574,"twenty":-39.211201,"median":-28.941227,"eighty":-2.231636,"marketCap":61612014},{"date":"2025-07-18","current":-1.445848,"twenty":-38.951524,"median":-26.47895,"eighty":-2.071335,"marketCap":56683052},{"date":"2025-07-25","current":-1.492996,"twenty":-38.778406,"median":-23.18045,"eighty":-1.788452,"marketCap":58531413},{"date":"2025-08-01","current":-1.363969,"twenty":-38.461024,"median":-4.211819,"eighty":-1.599863,"marketCap":53473066},{"date":"2025-08-08","current":-1.192039,"twenty":-37.681993,"median":-3.913221,"eighty":-1.56205,"marketCap":46732712},{"date":"2025-08-15","current":-1.049812,"twenty":-35.924207,"median":-3.708916,"eighty":-1.47728,"marketCap":41156825},{"date":"2025-08-22","current":-1.235626,"twenty":-34.756715,"median":-3.629891,"eighty":-1.43139,"marketCap":55976498},{"date":"2025-08-29","current":-2.188683,"twenty":-34.62078,"median":-3.413707,"eighty":-1.438305,"marketCap":99152025},{"date":"2025-09-05","current":-2.237683,"twenty":-34.603002,"median":-3.107007,"eighty":-1.445848,"marketCap":101371847},{"date":"2025-09-12","current":-2.499018,"twenty":-34.471881,"median":-2.946702,"eighty":-1.452134,"marketCap":113210894},{"date":"2025-09-19","current":-2.254017,"twenty":-34.136436,"median":-2.800306,"eighty":-1.47728,"marketCap":102111787},{"date":"2025-09-26","current":-1.649679,"twenty":-33.823857,"median":-2.731113,"eighty":-1.480423,"marketCap":74733989},{"date":"2025-10-03","current":-1.308636,"twenty":-33.061372,"median":-2.655961,"eighty":-1.454609,"marketCap":59284032},{"date":"2025-10-10","current":-1.427737,"twenty":-32.908875,"median":-2.515351,"eighty":-1.434953,"marketCap":64679566},{"date":"2025-10-17","current":-1.031861,"twenty":-32.775371,"median":-2.401018,"eighty":-1.427898,"marketCap":46745520},{"date":"2025-10-24","current":-0.812939,"twenty":-32.699041,"median":-2.29485,"eighty":-1.394458,"marketCap":36827864},{"date":"2025-10-30","current":-1.259258,"twenty":-32.577822,"median":-2.286683,"eighty":-1.381414,"marketCap":57047084}],"updateTime":1761951791571},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WGRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2574010782","title":"Wellgistics Health Inc - Eric Sherb Appointed Interim CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2574010782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574010782?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:17","pubTimestamp":1760127442,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR2PN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2574107829","title":"Wellgistics Health Inc announces CEO COO and CFO resignations appoints Eric Sherb as interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2574107829","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574107829?lang=en_us&edition=fundamental","pubTime":"2025-10-11 04:16","pubTimestamp":1760127391,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. announced that Brian Norton has resigned as Chief Executive Officer, Tony Madsen has resigned as Chief Operating Officer, and Mark DiSiena has resigned as Chief Financial Officer, all effective October 6, 2025. The company has appointed Eric Sherb as interim Chief Financial Officer, effective October 7, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nNDL37kQ9w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2573896959","title":"Wellgistics Health Inc Announces New Leadership Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2573896959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573896959?lang=en_us&edition=fundamental","pubTime":"2025-10-07 05:56","pubTimestamp":1759787800,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc ( ($WGRX) ) has issued an update. Wellgistics Health Inc. announced significant changes to its board of directors and execut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-inc-announces-new-leadership-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-inc-announces-new-leadership-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2573698611","title":"Wellgistics Health Inc. Announces Board Shakeup: New Directors Appointed Following Removals and Resignation","url":"https://stock-news.laohu8.com/highlight/detail?id=2573698611","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573698611?lang=en_us&edition=fundamental","pubTime":"2025-10-07 05:31","pubTimestamp":1759786290,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. has announced changes to its board of directors. Rebecca Shanahan and Michael Peterson have been removed from the board, while Donald Anderson has resigned. The company has appointed Donald Fell, Prashant Patel, Steven D. Lee, and Howard Doss as new board members. Committee assignments have also been updated, with Fell joining the Nominating and Compensation Committees, Lee joining the Ethics Committee, and Doss becoming chairman of the Audit Committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nNDL4LV3ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2572631135","title":"Wellgistics Health Inc Announces Successful Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2572631135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572631135?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:49","pubTimestamp":1759355389,"startTime":"0","endTime":"0","summary":"An announcement from Wellgistics Health Inc ( ($WGRX) ) is now available. On September 25, 2025, Wellgistics Health, Inc. announced a public offeri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-inc-announces-successful-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wellgistics-health-inc-announces-successful-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2572684845","title":"Wellgistics Health Inc. Announces $5 Million Public Offering of Common Stock and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2572684845","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572684845?lang=en_us&edition=fundamental","pubTime":"2025-10-02 05:22","pubTimestamp":1759353748,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. , a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, has announced the pricing of a $5 million public offering. The offering consists of 7,142,862 shares of common stock, together with warrants to purchase an equal number of shares at a combined price of $0.70 per share and associated warrant. The warrants are immediately exercisable at $0.70 per share and will expire five years from the date of issuance. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering. Wellgistics Health intends to use the net proceeds for working capital and general corporate purposes, which may include operating expenses, research and development, and potential acquisitions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDL6GPd98:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2571434213","title":"Wellgistics Health Inc. and TheracosBio Announce Partnership to Expand Nationwide Access to Brenzavvy Through 6,500 Pharmacies","url":"https://stock-news.laohu8.com/highlight/detail?id=2571434213","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571434213?lang=en_us&edition=fundamental","pubTime":"2025-09-30 20:00","pubTimestamp":1759233634,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. and TheracosBio Announce Partnership to Expand Nationwide Access to Brenzavvy Through 6,500 Pharmacies. Wellgistics Health Inc. has announced a new strategic collaboration with TheracosBio to expand nationwide access to Brenzavvy , an FDA-approved therapy for type 2 diabetes. The agreement will make Brenzavvy available through Wellgistics Health's network of more than 6,500 independent and chain pharmacies across the United States, as well as through direct-to-patient delivery channels. The initiative leverages Wellgistics Health's technology-enabled distribution platform to bypass traditional intermediaries, aiming to reduce costs and improve affordability for patients. The rollout is scheduled to begin in the fourth quarter of 2025, and participating pharmacies will provide patient counseling, adherence support, and care coordination as part of the program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL196xX1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2570798026","title":"Wellgistics Health prices 7.14M share offering at 70c per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2570798026","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570798026?lang=en_us&edition=fundamental","pubTime":"2025-09-26 08:55","pubTimestamp":1758848110,"startTime":"0","endTime":"0","summary":"The deal is priced below last closing price of $1.01. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. Published ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wellgistics-health-prices-7-14m-share-offering-at-70c-per-share-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wellgistics-health-prices-7-14m-share-offering-at-70c-per-share-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2570383023","title":"Wellgistics Health Inc. Announces $5 Million Public Offering of Shares and Warrants at $0.70 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2570383023","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570383023?lang=en_us&edition=fundamental","pubTime":"2025-09-26 08:01","pubTimestamp":1758844877,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. , a leader in pharmaceutical distribution and digital prescription services, has announced the pricing of a $5 million public offering. The offering consists of 7,142,862 shares of common stock and accompanying warrants to purchase an equal number of shares, both priced at $0.70 per share and warrant. The warrants will be immediately exercisable at $0.70 per share and will expire five years from the date of issuance. H.C. Wainwright & Co. is serving as the exclusive placement agent for the transaction. Wellgistics Health plans to use the net proceeds for working capital, general corporate purposes, research and development, and potential acquisitions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics He","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL1PwcfD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2565568167","title":"Wellgistics Health Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2565568167","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565568167?lang=en_us&edition=fundamental","pubTime":"2025-09-05 20:30","pubTimestamp":1757075432,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. , a leader in pharmaceutical distribution and AI-powered pharmacy fulfillment, is set to present at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, September 8, 2025, at 1:30 p.m. ET. Brian Norton, CEO, along with the executive leadership team, will showcase the company's strategic vision and ongoing innovations in the industry.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on September 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nNDLbfBdjQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2563072979","title":"BRIEF-Wellgistics Health Enters $1.3 Million Loan Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2563072979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563072979?lang=en_us&edition=fundamental","pubTime":"2025-08-30 05:08","pubTimestamp":1756501688,"startTime":"0","endTime":"0","summary":"BRIEF-Wellgistics Health Enters $1.3 Million Loan Agreement Aug 29  - Wellgistics Health Inc WGRX.O:WELLGISTICS HEALTH - ENTERS $1.3 MILLION LOAN AGREEMENT - SEC FILINGWELLGISTICS HEALTH INC - AGILE LOAN MATURES ON APRIL 8, 2026 - SEC FILINGFurther company coverage: WGRX.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UL1F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2563072921","title":"Wellgistics Health Inc - Agile Loan Matures on April 8, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2563072921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563072921?lang=en_us&edition=fundamental","pubTime":"2025-08-30 05:06","pubTimestamp":1756501578,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250829:nFWN3UL1F3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2560098811","title":"Wellgistics Health H1 2025 Revenue On Pro Forma Basis $18.65M Up From $18.25M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2560098811","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560098811?lang=en_us&edition=fundamental","pubTime":"2025-08-20 21:07","pubTimestamp":1755695244,"startTime":"0","endTime":"0","summary":"Wellgistics Health H1 2025 Revenue On Pro Forma Basis $18.65M Up From $18.25M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47232954/wellgistics-health-h1-2025-revenue-on-pro-forma-basis-18-65m-up-from-18-25m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX"],"gpt_icon":0},{"id":"2560106443","title":"Wellgistics Health Inc. Reports $18.65 Million Revenue in H1 2025, Slight Increase from $18.25 Million in H1 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2560106443","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560106443?lang=en_us&edition=fundamental","pubTime":"2025-08-20 21:00","pubTimestamp":1755694826,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc.  reported financial results for the second fiscal quarter ending June 30, 2025. The company's revenue on a pro forma basis for the first half of 2025 stood at $18.65 million, compared to $18.25 million in the first half of 2024, reflecting a slight increase. Since its initial public offering in February 2025, Wellgistics Health has consolidated its operations, streamlined staffing, and upgraded its ERP system to support growth. The company is also expanding its direct-to-patient programs, leveraging a network of over 6,500 independent pharmacies and 200 manufacturers to enhance its reach in therapeutic areas such as diabetes, weight loss, chronic pain, sleep disorders, and men's and women's health. The CEO emphasized the company's focus on accelerating growth through strategic funding and expanding access via its direct-to-patient delivery models.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL7x0Bz9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX"],"gpt_icon":0},{"id":"2559626889","title":"Wellgistics Health Inc - on August 13, 2025, Terminates $50 Mln Eloc Purchase Agreement - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2559626889","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559626889?lang=en_us&edition=fundamental","pubTime":"2025-08-15 05:02","pubTimestamp":1755205327,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nFWN3U61BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2559961258","title":"Wellgistics Health Inc. Delays Quarterly Report Due to Change in Accounting Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961258","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961258?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:11","pubTimestamp":1755202263,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the financial period ended June 30, 2025. The delay is attributed to the recent change in the company's independent registered public accounting firm, as Suri & Co. was replaced by UHY LLP. The company has indicated that the report could not be filed within the prescribed time period without unreasonable effort or expense.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 14, 2025, and is solely responsible for the inform","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL7y9f4r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2550573032","title":"Wellgistics Health Inc. Replaces Suri & Co. with UHY LLP as New Accounting Firm Following Going Concern Note","url":"https://stock-news.laohu8.com/highlight/detail?id=2550573032","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550573032?lang=en_us&edition=fundamental","pubTime":"2025-07-09 05:01","pubTimestamp":1752008467,"startTime":"0","endTime":"0","summary":"**Wellgistics Health Inc. Changes Accounting Firms Amid Going Concern Note** On July 7, 2025, Wellgistics Health Inc. announced a change in its independent registered public accounting firm, dismissing Suri & Co., Chartered Accountants, and appointing UHY LLP as its new auditor. The decision was made by the company's Board of Directors following the issuance of Suri's reports on Wellgistics' consolidated financial statements for the years ended December 31, 2024, and 2023. These reports contained a note regarding the company's ability to continue as a going concern, although they did not include any adverse opinions or disclaimers. The company confirmed that there were no disagreements or reportable events with Suri that would have required disclosure. UHY LLP has been engaged without any prior consultations on accounting or auditing matters with the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL2Lp10R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2550573083","title":"Wellgistics Health Inc. Files Initial Beneficial Ownership Statement, Naming Michael Peterson as Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2550573083","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550573083?lang=en_us&edition=fundamental","pubTime":"2025-07-09 05:00","pubTimestamp":1752008447,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Michael L. Peterson as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 08, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDLbQz7X8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0},{"id":"2546212458","title":"Wellgistics Health Inc. Reports Major Expansion in Q2 2025 with 116 New Manufacturer Partnerships and Over 12,400 New Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2546212458","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546212458?lang=en_us&edition=fundamental","pubTime":"2025-06-25 19:45","pubTimestamp":1750851917,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. Reports Major Expansion in Q2 2025 with 116 New Manufacturer Partnerships and Over 12,400 New Products. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wellgistics Health Inc. published the original content used to generate this news brief via ACCESS Newswire  on June 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL74Pt5K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Wellgistics Health Inc. Reports Major Expansion in Q2 2025 with 116 New Manufacturer Partnerships and Over 12,400 New Products","news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","WGRX"],"gpt_icon":0},{"id":"2542769319","title":"Wellgistics Health Inc. Joins Forces with OptiSource to Bolster Independent Pharmacies","url":"https://stock-news.laohu8.com/highlight/detail?id=2542769319","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542769319?lang=en_us&edition=fundamental","pubTime":"2025-06-10 19:45","pubTimestamp":1749555919,"startTime":"0","endTime":"0","summary":"Wellgistics Health Inc. has announced its new partnership with OptiSource, LLC, a group purchasing organization known for offering innovative business solutions and cost-saving services. By joining OptiSource, Wellgistics Health aims to enhance its purchasing power and product access, providing increased support to independent pharmacies. This collaboration will allow Wellgistics Health to offer competitive pricing on generics, an expanded range of specialty items, and a deeper formulary, positioning independent pharmacies to better compete against larger chains. Brian Norton, CEO of Wellgistics Health, emphasized that the partnership with OptiSource is a testament to their commitment to providing independent pharmacies with enhanced supply chain confidence and resources.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250610:nNDL1J1RvK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGRX","BK4175"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}